MXPA05010413A - Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona. - Google Patents

Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.

Info

Publication number
MXPA05010413A
MXPA05010413A MXPA05010413A MXPA05010413A MXPA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A
Authority
MX
Mexico
Prior art keywords
preparing
polymorph
rosiglitazone maleate
compound
rosiglitazone
Prior art date
Application number
MXPA05010413A
Other languages
English (en)
Spanish (es)
Inventor
Michael John Sasse
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MXPA05010413A publication Critical patent/MXPA05010413A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA05010413A 2003-03-28 2004-03-25 Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona. MXPA05010413A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
PCT/GB2004/001306 WO2004085435A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate

Publications (1)

Publication Number Publication Date
MXPA05010413A true MXPA05010413A (es) 2005-11-04

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010413A MXPA05010413A (es) 2003-03-28 2004-03-25 Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.

Country Status (18)

Country Link
US (1) US20070167494A1 (https=)
EP (1) EP1615918A1 (https=)
JP (1) JP2006521340A (https=)
KR (1) KR20050120670A (https=)
CN (1) CN1768057A (https=)
AU (2) AU2004224068A1 (https=)
BR (1) BRPI0408752A (https=)
CA (1) CA2520249A1 (https=)
EA (1) EA009331B1 (https=)
EC (1) ECSP056038A (https=)
GB (1) GB0307259D0 (https=)
IS (1) IS8087A (https=)
MA (1) MA27727A1 (https=)
MX (1) MXPA05010413A (https=)
NO (1) NO20054911L (https=)
OA (1) OA13042A (https=)
WO (1) WO2004085435A1 (https=)
ZA (1) ZA200507100B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
WO2018140092A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
ES3024958T3 (en) 2017-09-21 2025-06-05 Neurocrine Biosciences Inc High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ,インコーポレイテッド 特定のvmat2インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
PL351685A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Novel pharmaceutical
DE60004658T2 (de) * 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
OA13042A (en) 2006-11-10
IS8087A (is) 2005-10-24
EA200501527A1 (ru) 2006-02-24
EA009331B1 (ru) 2007-12-28
CN1768057A (zh) 2006-05-03
BRPI0408752A (pt) 2006-03-28
ZA200507100B (en) 2006-07-26
NO20054911L (no) 2005-10-24
KR20050120670A (ko) 2005-12-22
AU2008237610A1 (en) 2008-11-27
US20070167494A1 (en) 2007-07-19
JP2006521340A (ja) 2006-09-21
AU2004224068A1 (en) 2004-10-07
WO2004085435A1 (en) 2004-10-07
EP1615918A1 (en) 2006-01-18
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
ECSP056038A (es) 2006-01-27
GB0307259D0 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
EP1354987A4 (en) MONOCRYSTAL OF SILICON CARBIDE AND METHOD AND DEVICE FOR PRODUCING SAME
WO2004080889A3 (en) Crystalline membranes
IL169146A0 (en) Process for the production of 2'-branched nucleosides
PL375409A1 (en) Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
ZA200410000B (en) Method for producing C13-alcohol mixtures
IL183844A0 (en) Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
MXPA05010413A (es) Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.
SI1697326T1 (sl) Kristalna oblika kinolinske spojine in postopek za njeno pripravo
MY145265A (en) Amorphous ritonavir
WO2004043920A8 (en) Polymorphs of bicifadine hydrochloride
WO2005061493A3 (en) Polymorphic form b2 of ziprasidone base
WO2005000242A3 (en) Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid
WO2006023659A3 (en) Novel polymorphs of azabicyclohexane
PL374503A1 (en) Process for preparing crystalline form i of cabergoline
WO2007016355A3 (en) Process for the synthesis of progesterone receptor modulators
TWI262969B (en) Method for growth of silicon carbide single crystal, silicon carbide seed crystal, and silicon carbide single crystal
TW200617224A (en) Production process of periodic table group 13 metal nitride crystal and production method of semiconductor device using the same
IL163779A0 (en) Process for preparing crystalline form i of cabergoline
IL197970A (en) Process for making piperidinyl-sulfanyl-acetyl-motilines
TW200505932A (en) Apparatus for producing fluoride crystal
PT1948626E (pt) Processo para a preparação de delmopinol e de seus derivados
AU2003219423A1 (en) Process for the isolation of high purity crystalline citalopram base
EP1780203A3 (en) Enantioselective alkylation of tricyclic compounds
WO2004016589A3 (en) Process for production of highly pure donepezil hydrochloride
AU2003259002A1 (en) Process for manufacturing crystals of growth hormone